Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients

NCT02758678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-10-19

No results posted yet for this study

Summary

Purpose:

Selectins are vascular cell adhesion molecules involved in adhesive interactions of leukocytes and platelets and endothelium within the blood circulation.

Plasma soluble P selectin (sP-selectin), is a one of member of selectin family, an adhesion molecule and component of the membrane of the platelet alpha granulate has been proposed as a one marker of platelet activation. In this study we evaluate of expression of P selectin on platelets of blood between serum samples from lung cancer and healthy individuals.

Conditions

Interventions

BIOLOGICAL

A single 2 ml heparinised peripheral blood sample

A single 2 ml heparinised peripheral blood sample was centrifuges to get serum specimens. Serum separation and Raman spectroscopy analysis:

Sponsors & Collaborators

  • University in Zielona Góra

    collaborator OTHER
  • Science and Technology Park, Center of Innovation Technologies for Human Health

    lead INDUSTRY

Principal Investigators

  • Edyta I Wolny-Rokicka, MD.PhD · Clinicial Hospital in Zielona Góra,Radiotherapy Department ul Zyty 26, Zielona Góra, Poland

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758678 on ClinicalTrials.gov